-Fmoc-protected amino acids for solid phase peptide synthesis were purchased from Bachem or AGTC Bioproducts. Buffers, reagents and solvents were purchased from Sigma Aldrich. Reagents were obtained from either Sigma Aldrich, Alfa Aeser, Chem-impex, Bachem, Acros or AGTC Bioproducts. NMR MATCH tubes were from Wilgenburg. Activity assays used KDM6B1141-1590, which was expressed recombinantly in Escherichia coli, as previously described 1 .
Synthesis of lysine analogues
Synthesis of 2-Fmoc-7-dimethyl-octanoic acid, 
-methyl-lysine (all as hydrochlorides) were developed, which provided the compounds in a purified form for characterisation (see below). Reactions were carried out in round-bottomed flasks with magnetic stirring, and were performed under air conditions unless stated otherwise.
Electronic Supplementary
, purifications were performed on a Biotage flash purification system with Grace Solve Revelaris or Biotage SiO2 and Rf-C18 columns. The GraceResolve standard settings were as follows: 4 g column (12 mL/min, 1 Column Volume (CV): 5mL), 12 g column (24 mL/min, 16 mL), 24 g column (24 mL/min, 1 CV: 32 mL), 40 g column (40 mL/min, 1 CV: 50 mL), 80 g column (60 mL/min, 1 CV: 100 mL) and 120 g column (80 mL/min, 1 CV: 160 mL). Biotage standard settings were as follows: 10 g column (36 mL/ min, 1 CV: 15 mL), 25 g column (75 mL/min, 1 CV: 33 mL), 50 g column (100 mL/min, 1 CV: 66 mL) and 100 g column (100 mL/min, CV: 132 mL). Fraction collection was at 254 nm and monitoring was at 230 nm. Yields depicted are of isolated material. Reaction monitoring was carried out on Merck thin layer chromatography (TLC) plates with visualisation at 254 nm and by KMnO4 or ninhydrin staining. Monitoring by liquid chromatography-mass spectrometry (LC-MS) was also used.
1 H NMR analyses were performed at 400 MHz or 500 MHz.
13 C NMR was performed at 100 MHz or 125 MHz on Bruker electrospin 400 with samplXpress or Bruker electrospin 500 spectrometers. Chemical shifts are given in (δ) ppm and couplings are reported in Hz. Abbreviations for couplings are as follows: s = singlet, d = doublet, t = triplet, q = quadruplet, quint = quintet, hept = heptet, b = broad, m = multiplet and app t = apparent triplet. Solvents used for NMR were CDCl3-d1, MeOD-d4 or DMSO-d6, which were all from Sigma Aldrich. Assigned protons are indicated as underlined and italic and aromatic protons on the Fmoc group are assigned as depicted below. Infrared spectra were obtained using an IR Bruker tensor 27 spectrometer and optical rotation data were furnished using a Schmidt Haensch polarimeter with a 10 cm cell at 298 K. Low resolution mass spectrometry was carried out on an Agilent 6120 quadruple LC/MS Agilent 1260 in combination with Waters sample manager 2777. LC-MS analyses were performed using an Agilent 6120 quadruple LC/MS Agilent 1200. All small molecules were analysed in positive ion mode using electron spray ionisation (ESI). Lyophilisation was performed using a Scanvac Coolsafe lyophiliser. Fmoc-Orn-OH . HCl (356 mg, 0.91 mmol, 1.0 equiv.) was dissolved in MeOH (10 mL) before addition of acetone (1 mL). NaCNBH3 (86 mg, 1.37 mmol, 1.5 equiv.) was then added and the reaction was left stirring for 2 h. Formalin (0.5 mL, 37%(aq), 6.15 mmol, 7 equiv.) was then added before addition of NaCNBH3 (86 mg, 1.37 mmol, 1.5 equiv.). The reaction was left stirring overnight (12 h) before addition of a few drops of conc. HCl and removal of the volatiles in vacuo. Acetone (10 mL) was then added to the residue followed by filtration. The supernatant was then collected and the volatiles were removed in vacuo. The resultant white solid (267 mg, 66%) was used directly in sold phase peptide synthesis without purification. To a suspension of Fmoc-lys(HCOOH)-OH (801 mg, 1.93 mmol, 1.0 equiv.) in EtOH (20 mL, 0.1M), acetaldehyde (1 mL, 17.8 mmol, 9.23 equiv.) was added followed by slow addition of NaBH3CN (268 mg, 4.25 mmol, 2.2 equiv.). The mixture was stirred for 45 min creating overtime a clear solution. TFA (300 μL) was added drop wise and the mixture was stirred for 3 min. In vacuo volatiles were removed and the crude was loaded on a Grace 40 g Rf-C18 column followed by biotage mediated purification. 3 CV (5%) equilibration, loading (~6 mL, 25%), 2 CV (5%), 20 CV (5 to 100%) MeCN in H2O (containing 0.01% TFA). Selected fractions were lyophilised yielding, 564 mg of white solid (1.33 mmol, 69%). The solid was redissolved in CH2Cl2 (5 mL, 0.27 M) and to the solution was added HCl in Et2O (2 mL, 2 M, 4 mmol, 3.0 equiv.) and volatiles were removed in vacuo. Azeotropically Et2O was removed with CH2Cl2 in vacuo (4x 10 mL A mixture of Fmoc-Orn-OH . HCl (990 mg, 2.53 mmol, 1.0 equiv.) in ethanol (20 mL) was stirred for 15 min to a clear solution. HCHO (1.00 mL, 37 %(aq), 13.42 mmol, 2.53 equiv) was added drop wise followed nu the addition of NaBH3CN (350 mg, 5.57 mmol, 2.20 equiv.). The mixture was stirred for 45 min until ESI-MS indicated reaction completion. To the solution 300 μL of TFA was added drop wise followed stirring for 15 min. The mixture was filtered through some cotton in a funnel, washed with 3x 10 mL of EtOH. The crude was obtained after removal of solvents in vacuo. The mixture was dissolved in 8 mL of MeCN/ H2O (1:5) and was purified on Rf-C18 column SNAP cartridge KP-C18-HS. (Gradient program: 2 CV 5% to 5%, 20 CV 5% to 100% of MeCN:H2O containing 0.01% TFA (v/v%)). Volatiles where removed upon lyophilization obtaining a white fluffy solid of 590 mg (61 %). The combined fractions were dissolved in DCM (5 mL) followed by the addition of HCl in Et2O (5 mL, 10 mmol, 2 M) to protonate the zwitter ionic specie. 
To a solution of Fmoc-Lys(me, Boc)-OH (573 mg, 1.19 mmol, 1.0 equiv.) in CH2Cl2 (5 mL, 0.24 M) was added HCl in Et2O (2 mL, 2 M, 4 mmol, 3.3 equiv.) while stirring at RT. The mixture was continued stirring for 16 h followed by the removal of volatiles under reduced pressure obtaining the crude as white solid. To a solution of Fmoc-Lys(me, HCl)-OH in EtOH (15 mL, 0.08 M), acetaldehyde (404 μL, 7.2 mmol, 6.0 equiv.) was added drop wise followed by NaBH3CN (169 mg, 2.69 mmol, 2.3 equiv.). The mixture was stirred for 1.5 h and progress of the reaction was determined by ESI-MS. TFA (380 μL, 4.57 mmol, 3.84 equiv.) and 1 mL of H2O was added followed by stirring at RT for 15 min. Volatiles were removed in vacuo and the crude was loaded on a Grace 40 g Rf-C18 column for biotage purification. 3 CV (5%) equilibration, loading (~15 mL, 25%), 2 CV (5%), 20 CV (5 to 100%) MeCN in H2O (containing 0.01% TFA). Selected fractions were lyophilized (yielding, 326 mg, 0.79 mmol, 67%), combined and dissolved in CH2Cl2 (5 mL, 0.16 M). To the solution was added slowly HCl in Et2O (1 mL, 2 M, 2 mmol, 1.68 equiv.) while stirring and volatiles were removed in vacuo. Azeotropically Et2O was removed with CH2Cl2 in vacuo (4x 10 mL) obtaining the title compound as a white solid. 
(S)-2-[Fluorenylmethyloxycarbonyl]amino-6-[isopropyl]amino-hexanoic acid hydrochloric acid (N α -Fmoc-N ε -isopropyl-lysine hydrochloride)
To a suspension of Fmoc-Lys(HCOOH)-OH (1.012 g, 2.5 mmol, 1.0 equiv.) in ethanol (20 mL) acetone (1 mL, 13.6 mmol, 5.4 equiv.) was added followed by the addition of NaBH3CN (179 mg, 2.85 mmol, 1.14 equiv). The mixture was monitored until completion with ESI-MS followed by quenching after 45 min with the addition of TFA (300 µL). The mixture was stirred for 3 minutes followed by filtration and washed with 3× of ethanol (10 mL). The supernatant was concentrated in vacuo followed by HPLC purification on Rf-C18 column. Biotage cartridge KP-C18-HS 30 g Rf-C18, 3 CV 5% equilibration, 2 CV 5%, 20 CV 5% to 100 % of MeCN (containing 0.01% TFA) in H2O (containing 0.01% TFA). The selected fractions were collected and combined followed by removal of volatiles by lyophilization. The white compound obtained (727 mg, yielding 71%) was protonated with HCl . Et2O (5 mL, 2 M, 10 mmol, 4.0 equiv.) followed by the removal of diethyl ether under reduced pressure and finally to the mixture was added 2× CH2Cl2 (10 mL) followed by azeotropic removal in vacuo of excessive amounts of diethyl ether, obtaining a white solid. 
(S)-2-[Fluorenylmethyloxycarbonyl]amino-6-[methyl, isopropyl]amino-hexanoic acid hydrochloric acid (N α -Fmoc-N ε -isopropyl-N ε -methyl-lysine hydrochloride)
To a suspension of Fmoc-Lys(HCOOH)-OH (1.003 g, 2.5 mmol, 1.0 equiv.) in ethanol (20 mL) acetone (1 mL, 13.6 mmol, 5.4 equiv.) was added drop wise followed by the addition of NaBH3CN (172 mg, 2.7 mmol, 1.08 equiv). The mixture was monitored until completion with ESI-MS followed by the addition of formaldehyde (900 µL, 15.0 mmol, 6.0 equiv.) and NaBH3CN (169 mg, 2.7 mmol, 1.08 equiv.). The reaction mixture was stirred until completion monitored by ESI-MS and after 1 h the addition of TFA (300 µL) quenched the reaction mixture. The mixture was filtered and the residue was washed 3× with ethanol (10 mL). The supernatant was concentrated in vacuo followed by purification on Rf-C18 column with biotage. Biotage cartridge KP-C18-HS 30 g Rf-C18, 3 CV 5% equilibration, 2 CV 5%, 20 CV 5% to 100% of MeCN (containing 0.01% TFA) in H2O (containing 0.01% TFA). The selected fraction were collected and combined followed by removal of volatiles by lyophilization. The white compound obtained (871 mg, yielding 82%) was protonated with HCl . Et2O (2 mL, 2 M, 4 mmol, 1.6 equiv.) followed by the removal of diethyl ether under reduced pressure and finally the mixture was 2× CH2Cl2 (10 mL) was added to remove excessive amounts of diethyl ether obtaining a white solid. 
Solid Phase Peptide Synthesis
Peptides were synthesised using a C336X peptide synthesiser (CS Bio, U. S. A.) on MBHA resin using standard Fmoc-based peptide synthesis. The peptides were cleaved from the resin using trifluoroacetic acid / triisopropylsilane (97.5/2.5 % v/v) and purified by reverse-phase high-performance liquid chromatography using a Vydac C18 column (Grace, U. S. A.).
MALDI-MS Activity Assays
MALDI-MS activity assays were carried out on samples containing KDM6B (2 µM), histone fragment peptide (10 µM), 2-oxoglutarate (50 µM), ascorbate (100 µM) and ammonium ferrous sulphate (10 µM, diluted from a 100 µM stock in H2O) in 50 mM HEPES buffer pH 7.5 (total volume = 20 µL). After incubation for one hour at 25 °C, the samples were quenched with MeOH (40 µL); 1 µL samples were spotted onto plates for analysis using a Waters MALDI Micro MX mass spectrometer. α-Cyano-4-hydroxycinnamic acid (CHCA) was used as the matrix. Observed masses for the peptides were within 1 Da of their predicted monocharged masses. For time-course experiments, aliquots from the reaction mixtures were taken at different time points before immediate quenching with methanol and spotting onto MALDI plates. Concentrations for each species were determined using the following equation.
[ ] = ×
MALDI-MS Inhibition/Competition Assays
KDM6B (1 µM) was pre-incubated with the histone fragment peptides (100 µM final concentration, 10 minutes, 25°C) prior to initiating reaction by addition of 2-oxoglutarate (50 µM), ascorbate (100 µM), ammonium ferrous sulphate (10 µM, diluted from a 100 µM stock in H2O) and H3K27Me3 21mer peptide (sequence: KAPRKQLATKAAR-Lys(Me3)-SAPATGG, 10 µM) in HEPES buffer (50 mM pH 7.5) (total volume = 20 µL). After incubation (3 minutes at 25 °C), reactions were quenched by addition MeOH (40 µL), after which 1 µL of each sample was spotted onto a MALDI plate with α-cyano-4-hydroxycinnamic acid (CHCA) matrix, and then analysed using a Waters MALDI Micro MX mass spectrometer. Percentage methylation and percentage demethylation relative to enzyme free control were calculated as above. Data were analysed using Dunnett's multiple comparison test on GraphPad Prism 7.
NMR Analyses
1 H NMR experiments with the Lys(iPr)-and Lys(Me/iPr)-containing peptides and KDM6B were carried out on a Bruker Avance AVIII 700 MHz spectrometer equipped with an inverse TCI cryoprobe optimised for 1 H observation and installed with TOPSPIN 2 software. Samples were prepared in Eppendorf tubes before being transferred to 2 mm MATCH NMR tubes and inserted into the spectrometer for analysis. Samples were prepared as follows; KDM6B (2 mg/mL, diluted from a 10 mg/mL stock in 10 mM HEPES, 300 mM NaCl, 1 mM dithiothreitol,tetradeuteropropionic acid (0.13 mg/mL) as an internal reference. After a brief optimisation of the spectrometer conditions, time-course data were collected using automated routines; multiple 1 H NMR experiments were collected sequentially, with each experiment consisting of 32 transients, with a total acquisition time of 168 seconds. The total lag time between sample preparation and the first analysis was 300-500 seconds. The solvent deuterium signal was used as an internal lock signal and the water resonance was reduced using presaturation or gradient suppression. Experiments with the Lys(Me/iPr) peptide sample were conducted at 292 K (experiments with the Lys(iPr) peptide sample were at 298 K).
1 H chemical shifts are reported relative to the solvent resonance (δH 4.7 ppm). 1 H NMR spectra of a sample containing KDM6B, the Lys(iPr) peptide, 2-oxoglutarate, ascorbate and ferrous iron after 5 minutes (blue) and one hour (red). Decreased intensity of the doublet resonance at δH 1.3 ppm is observed (corresponding to the Lys(iPr) isopropyl protons), with a concomitant small increase in the intensity of the singlet resonance at δH 2.2 ppm. Addition of authentic acetone to the sample resulted in an additional increase in the resonance, suggesting a product of de-isopropylation is acetone (B). Figure S5 . MALDI-MS spectrum of a sample containing KDM6B, the Lys(iPr) peptide, 2-oxoglutarate, ascorbate and ferrous iron after one hour incubation at 25 °C. The emergence of a new peak (asterisked) suggests loss of 63 Da from the Lys(iPr) peptide, which is larger than the mass of the isopropyl group. However, the relatively low intensity of the peak precludes assignment (note: there are likely two species with similar mass, based on the peak shape). Figure S6 . 1 H NMR spectra of KDM6B-catalysed oxidation of the Lys(Me/iPr) peptide. 1 H NMR spectra of a sample containing KDM6B, Lys(Me/iPr) peptide, 2-oxoglutarate, ascorbate and ferrous iron after 7 minutes (blue) and 35 minutes (red) reveal decreased intensities of the resonances at δH 1.2 ppm and δH 2.65 ppm, and concomitant emergence of new resonances at δH 1.15 ppm and δH 2.7 ppm. While the intensities of the new resonances are too low to fully assign, overlay of the spectra with that of an incubation of KDM4E, a histone H3 fragment peptide containing Lys(Me/iPr) at lysine-9, 2-oxoglutarate, ascorbate and ferrous iron (green), suggest the products of both reactions are identical, i.e. that KDM6B catalysis on Lys(Me/iPr) results in hydroxylation on the isopropyl methyl group. 
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